Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report

Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report

Abstract Background Immune checkpoint inhibitor (ICI) therapy is used in the management of advanced malignancies. Thyroid function abnormalities have been reported, but more evidence is needed to substantiate the subtypes and course of thyroid disease associated with this treatment. Case presentatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Juul Thomsen, Stine Linding Andersen, Nanna Maria Uldall Torp, Stig Andersen, Allan Carlé
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Thyroid Research
Subjects:
PD-1
CTLA-4
Immune-related adverse events
Hypothyroidism
Hyperthyroidism
Online Access:https://doi.org/10.1186/s13044-025-00254-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items